Description
Product Overview / 商品概要
Tezspire Subcutaneous Injection 210mg Syringe (テゼスパイア皮下注210mgシリンジ)
Generic: Tezepelumab (Genetical Recombination) / テゼペルマブ(遺伝子組換え)
Therapeutic Category: Human Anti-TSLP Monoclonal Antibody / ヒト抗TSLPモノクローナル抗体
Manufactured by: AstraZeneca K.K. / アストラゼネカ株式会社
Composition & Specification / 組成・規格
Active Ingredient: Tezepelumab (Genetical Recombination) 210mg per 1 syringe (1.91mL) / 1シリンジ(1.91mL)中 テゼペルマブ(遺伝子組換え)210mg
Additives: L-Proline 48mg, Polysorbate 80 0.19mg, pH adjuster per 1 syringe (1.91mL) / 1シリンジ(1.91mL)中 L-プロリン 48mg、ポリソルベート80 0.19mg、pH調節剤
Appearance: Colorless to pale yellow, clear to opalescent solution. pH 4.9–5.5, osmolality ratio approximately 1 (relative to physiological saline)
外観: 無色~淡黄色の澄明~乳白光を呈する液である。pH 4.9~5.5、浸透圧比 約1(生理食塩液に対する比)
Indications / 効能効果
EN: Bronchial asthma (limited to patients with severe or refractory disease whose symptoms cannot be controlled with existing treatments); Chronic rhinosinusitis with nasal polyps (limited to patients with inadequate response to existing treatments)
JA: 気管支喘息(既存治療によっても喘息症状をコントロールできない重症又は難治の患者に限る)、鼻茸を伴う慢性副鼻腔炎(既存治療で効果不十分な患者に限る)
Dosage and Administration / 用法用量
EN: The usual dose for adults and pediatric patients aged 12 years and older is 210mg of tezepelumab (genetical recombination) administered subcutaneously once every 4 weeks. The usual dose for adults is 210mg of tezepelumab (genetical recombination) administered subcutaneously once every 4 weeks.
JA: 〈気管支喘息〉通常、成人及び12歳以上の小児にはテゼペルマブ(遺伝子組換え)として1回210mgを4週間隔で皮下に注射する。〈鼻茸を伴う慢性副鼻腔炎〉通常、成人にはテゼペルマブ(遺伝子組換え)として1回210mgを4週間隔で皮下に注射する。
Contraindications / 禁忌
EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者
Regulatory Information / 規制情報
Approval No.: 30400AMX00402
Sales Started: November 2022 / 2022年11月
Classification Code: 87229
Storage: Store at 2–8°C / 2~8℃で保存
Shelf Life: 36 months / 36箇月
Packaging / 包装
Main Package (for sale): 1.91mL [1 kit (prefilled syringe with 27G needle x 1)] / 1.91mL[1キット(注射針(27G)付きプレフィルドシリンジ×1)]
Other Available Packages (by special order): 1.91mL [1 kit (prefilled syringe with 27G needle x 1)]
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.




Reviews
There are no reviews yet.